Global Precision Oncology: A Call to Action on Expanding Access to Targeted Cancer Therapies

At the health systems level, lack of diagnostic ability, inadequate access to trained providers, and limited drug availability provide significant barriers to cancer care delivery. This article outlines an urgent call to action to improve access to precision oncology therapies in lower- and middle-income countries, drawing upon lessons from international efforts in oncology and infectious disease.

Automated summary

The article calls for improving access to precision oncology therapies in lower- and middle-income countries, highlighting lack of diagnostic ability, trained providers, and drug availability as significant barriers to cancer care delivery. It draws upon lessons from international efforts in oncology and infectious disease to make this urgent call to action.